Table 2.
Clinical features of PCD patients COVID-positive in comparison to non-COVID (mean ± SD or number and percentages) and the statistical significance of differences.
| COVID-Acquired (12) 7F, 5M |
Non-COVID-Acquired (28) 16F, 12M |
Statistical Significance (p) | |
|---|---|---|---|
| Age (years) | 35.9 ± 12.4 | 37 ± 18.5 | 0.85 |
| BMI (kg/m2) | 23.2 ± 3.3 | 20.1 ± 4.1 | 0.03 * |
| Situs viscerum inversus | 4 (33.3%) | 18 (64.3%) | 0.09 |
| Chronic rhinosinusitis | 9 (75%) | 18 (64.3%) | 0.71 |
| Bronchiectasis | 10 (83.3%) | 19 (67.8%) | 0.45 |
| Colonization by P. aeruginosa | 5 (41.7%) | 10 (35.7%) | 0.73 |
| Bronchial asthma | 2 (16.7%) | 6 (21.4%) | 1.0 |
| Allergy | 2 (16.7%) | 8 (28.6%) | 0.7 |
| Number of vaccine doses | 3.5 ± 0.7 | 3.4 ± 0.9 | 0.73 |
| FEV1 | 73.4 ± 18.8 | 83.1 ± 16.2 | 0.1 |
| SNOT-22 | 27.1 ± 20.5 | 29.9 ± 23.8 | 0.72 |
* Statistically significant.